» Articles » PMID: 26069580

Gene Therapy for Cartilage Repair

Overview
Journal Cartilage
Date 2015 Jun 13
PMID 26069580
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The concept of using gene transfer strategies for cartilage repair originates from the idea of transferring genes encoding therapeutic factors into the repair tissue, resulting in a temporarily and spatially defined delivery of therapeutic molecules to sites of cartilage damage. This review focuses on the potential benefits of using gene therapy approaches for the repair of articular cartilage and meniscal fibrocartilage, including articular cartilage defects resulting from acute trauma, osteochondritis dissecans, osteonecrosis, and osteoarthritis. Possible applications for meniscal repair comprise meniscal lesions, meniscal sutures, and meniscal transplantation. Recent studies in both small and large animal models have demonstrated the applicability of gene-based approaches for cartilage repair. Chondrogenic pathways were stimulated in the repair tissue and in osteoarthritic cartilage using genes for polypeptide growth factors and transcription factors. Although encouraging data have been generated, a successful translation of gene therapy for cartilage repair will require an ongoing combined effort of orthopedic surgeons and of basic scientists.

Citing Articles

Forty Years of the Use of Cells for Cartilage Regeneration: The Research Side.

Roseti L, Cavallo C, Desando G, DAlessandro M, Grigolo B Pharmaceutics. 2025; 16(12.

PMID: 39771600 PMC: 11677864. DOI: 10.3390/pharmaceutics16121622.


Knee Arthroscopy in the Era of Precision Medicine: A Comprehensive Review of Tailored Approaches and Emerging Technologies.

Rathod V, Shrivastav S, Gharpinde M Cureus. 2024; 16(10):e70932.

PMID: 39502973 PMC: 11537776. DOI: 10.7759/cureus.70932.


Tissue engineering and future directions in regenerative medicine for knee cartilage repair: a comprehensive review.

Primorac D, Molnar V, Tsoukas D, Uzieliene I, Tremolada C, Brlek P Croat Med J. 2024; 65(3):268-287.

PMID: 38868973 PMC: 11157252.


The current status of various preclinical therapeutic approaches for tendon repair.

Liang W, Zhou C, Deng Y, Fu L, Zhao J, Long H Ann Med. 2024; 56(1):2337871.

PMID: 38738394 PMC: 11095292. DOI: 10.1080/07853890.2024.2337871.


Tutorial: design and execution of CRISPR in vivo screens.

Braun C, Adames A, Saur D, Rad R Nat Protoc. 2022; 17(9):1903-1925.

PMID: 35840661 DOI: 10.1038/s41596-022-00700-y.


References
1.
Freed L, Grande D, Lingbin Z, Emmanual J, Marquis J, Langer R . Joint resurfacing using allograft chondrocytes and synthetic biodegradable polymer scaffolds. J Biomed Mater Res. 1994; 28(8):891-9. DOI: 10.1002/jbm.820280808. View

2.
Pangborn C, Athanasiou K . Growth factors and fibrochondrocytes in scaffolds. J Orthop Res. 2005; 23(5):1184-90. DOI: 10.1016/j.orthres.2005.01.019. View

3.
SIEGEL M, Roberts C . Meniscal allografts. Clin Sports Med. 1993; 12(1):59-80. View

4.
Grossin L, Cournil-Henrionnet C, Pinzano A, Gaborit N, Dumas D, Etienne S . Gene transfer with HSP 70 in rat chondrocytes confers cytoprotection in vitro and during experimental osteoarthritis. FASEB J. 2006; 20(1):65-75. DOI: 10.1096/fj.04-2889com. View

5.
Ivkovic A, Pascher A, Hudetz D, Jelic M, Haspl M, Windhager R . Current concepts in gene therapy of the musculoskeletal system. Acta Chir Orthop Traumatol Cech. 2006; 73(2):115-22. View